Prelude Therapeutics to Participate in Citizens Life Sciences Conference

Provided By GlobeNewswire

Last update: May 1, 2025

WILMINGTON, Del., May 01, 2025 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Prelude) (Nasdaq: PRLD), a clinical-stage precision oncology company, announced today that the Company will participate in the Citizens Life Sciences Conference taking place in New York on May 7, 2025.